Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 AlteredExpression disease BEFREE No relationship was found between leptin levels and severity of steatosis. 11095344 2000
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease CTD_human Leptin may play a role in tamoxifen-induced hepatic steatosis. 12661780 2003
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 AlteredExpression disease BEFREE For both genotypes, overweight patients had significantly more steatosis and increased insulin and leptin levels. 14642624 2003
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease BEFREE The main aim of this study was to examine the relationship of the leptin system in steatosis and nonalcoholic steatohepatitis (NASH). 17032406 2006
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 AlteredExpression disease BEFREE Along with downregulation of BDNF to approximately 30% of wild-type animals, Timo/Timo mice exhibited increased body weight and fat content with hepatic steatosis and elevated serum levels of leptin, cholesterol, and LDL cholesterol. 17652166 2007
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease CTD_human A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. 19716478 2009
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 AlteredExpression disease BEFREE These changes were also accompanied by altered serum levels of leptin, adiponectin, and insulin, as well as by prevention of steatosis (fatty liver) in ActRIIB-mFc-treated ORX mice. 20573726 2010
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 GeneticVariation disease BEFREE Homozygous Leptin(145E/145E) mutant mice exhibited morbid obesity, accompanied by adipose hypertrophy, energy imbalance, and liver steatosis. 21151569 2010
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease BEFREE In genotype-3 infected patients, SVR was associated only with fibrosis stage and lower homeostasis model assessment insulin resistance at baseline, but not with the degree of steatosis or leptin concentrations. 22171144 2011
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 AlteredExpression disease BEFREE Elevated leptin level seems to be a feature of steatosis, and it appears to increase as hepatocyte steatosis develops. 22215535 2012
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 AlteredExpression disease BEFREE In logistic regression analysis, only insulin resistance was associated with portal inflammation), lobular inflammation and steatosis; liver steatosis was related with leptin levels, too. 22530350 2012
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 AlteredExpression disease BEFREE Administering leptin in chow-fed mice caused increased hepatic expression of CD14 via STAT3 signaling, resulting in hyperreactivity against low-dose LPS without steatosis. 22768838 2012
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 AlteredExpression disease BEFREE Adoptive transfer of iNKT cells into obese mice or in vivo activation of iNKT cells via their lipid ligand, alpha-galactocylceramide, decreased body fat, triglyceride levels, leptin, and fatty liver and improved insulin sensitivity through anti-inflammatory cytokine production by adipose-derived iNKT cells. 22981538 2012
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease BEFREE Leptin improved the fatty liver possibly by activating hepatic AMPK through the central and sympathetic nervous systems. 23024365 2012
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease BEFREE Rapid improvement of hepatic steatosis after initiation of leptin substitution in a leptin-deficient girl. 23651953 2013
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease CTD_human Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21. 23839791 2014
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease CTD_human Chronic exposure to low doses of pharmaceuticals disturbs the hepatic expression of circadian genes in lean and obese mice. 24525044 2014
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease BEFREE We investigated the liver effect of leptin independently of insulin sensitization and appetite suppression using hepatocyte-specific Pten-deficient (AlbCrePtenff) mouse, a model of severe fatty liver with insulin hypersensitivity. 25415231 2015
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease CTD_human Stevia-derived compounds attenuate the toxic effects of ectopic lipid accumulation in the liver of obese mice: a transcriptomic and metabolomic study. 25554529 2015
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease CTD_human In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice. 27712037 2017
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease BEFREE The probiotic mixture showed promise as a treatment for NAFLD pathogenesis, and may improve HFSD-induced steatosis through its effects on leptin, resistin, inflammatory biomarkers, and hepatic function markers. 28086768 2017
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 AlteredExpression disease BEFREE LEP levels showed an inverse relationship with the degree of steatosis, and RETN levels showed an inverse relationship with fibrosis stages. 28281237 2017
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 AlteredExpression disease BEFREE Our results suggest that mSJH exerts an anti-hepatic steatosis effect via activation of leptin and associated signaling cascades related to lipid metabolism. 28358008 2017
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease BEFREE Both liver tissue and blood samples were processed to evaluate steatosis and NASH changes in histology (Oil Red, Sirius Red and H&E); presence of endothelial damage (CD31, Moesin/p-Moesin, Akt/p-Akt, eNOS/p-eNOS), oxidative stress (iNOS) and fibrosis (αSMA, Col1, PDGF, VEGF) proteins in liver tissue; and inflammatory (IL6, IL10, MCP-1, IL17α, TNFα), liver biochemical function, and hormonal (leptin, ghrelin, visfatin and insulin) alterations in plasma. 28710554 2018
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.400 Biomarker disease BEFREE Alcohol exposure around conception increases obesity risk, alters plasma lipid and leptin profiles, and induces liver steatosis in a sex-specific manner. 29089335 2018